Webinar
Our live, hosted webinar is scheduled for
Tuesday, September 21
at 1:00 pm and again at 3:00 pm PST.
To register, please email marcom@diadexus.com
Microsoft Silverlight is required to view this webinar.
Please be visit microsoft.com/silverlight prior to 1:00 pm today
to ensure that your computer can view webinar.
Introduction to the PLAC Test for Lp-PLA2
The PLAC Test is the only blood test cleared by the FDA to aid in assessing risk for both coronary heart disease and ischemic stroke associated with atherosclerosis. View this short webinar, presented by Dr. Kenneth J. Colley, as an introduction to the PLAC Test for Lp-PLA2
Dr. Colley discusses the following key topics:
- Background and Lp-PLA2 Mechanism of Action
- Clinical Evidence
- Testing, Prognosis and Treatment
- Therapeutic Intervention
Kenneth J. Colley, M.D., Ph.D.
Dr. Colley is an accomplished physician-scientist with over 18 years experience in medicine and the life sciences industry, including pharmaceuticals, biotechnology and medical devices. Ken is Director of Medical Affairs for diaDexus Inc. He received his M.D. and Ph.D. in Molecular Pharmacology from Georgetown University and also holds a B.S. in Biological Sciences from Stanford University.